Women harboring germline pathogenic variants (PV) in the BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185) genes have a substantially elevated lifetime risk of BC, ranging from 69 to 72% [2]. This evidence concerns the gene BRCA2 and breast cancer.